Subscribe today!
Research Areas
Research Areas
Neuroscience
Cancer Research
Immunology
Infectious Disease & Vaccines
Hematology
Ophthalmology
Rare & Genetic Diseases
Dermatology
Internal Medicine
Metabolic Disease
Tools & Techniques
All Research Areas
News
Magazine
Multimedia
Multimedia
Webinars
eBooks
Podcasts
Infographics
Videos
Milestones - Articles
Explainers - Articles
Industry Perspectives
Compendiums
Whitepapers
Application Notes
All Multimedia
Research Areas
Research Areas
Neuroscience
Cancer Research
Immunology
Infectious Disease & Vaccines
Hematology
Ophthalmology
Rare & Genetic Diseases
Dermatology
Internal Medicine
Metabolic Disease
Tools & Techniques
All Research Areas
News
Magazine
Multimedia
Multimedia
Webinars
eBooks
Podcasts
Infographics
Videos
Milestones - Articles
Explainers - Articles
Industry Perspectives
Compendiums
Whitepapers
Application Notes
All Multimedia
Subscribe!
Subscribe Today!
Mel J. Yeates
This person does not yet have a bio.
Articles by Mel J. Yeates
| 3 min read
by
Mel J. Yeates
BNT162b2 becomes first authorized COVID-19 vaccine
Pfizer and BioNTech have achieved the first authorization for a vaccine against COVID-19
News
| 2 min read
by
Mel J. Yeates
A rapid COVID-19 breath test heads to trial
A human trial for COVID-19 ultra-rapid breath test has begun in Delhi, India…
Articles
| 3 min read
by
Mel J. Yeates
Valneva expands development for potential Lyme vaccine
Valneva and Pfizer collaboration expands pediatric development for VLA15 vaccine
News
| 2 min read
by
Mel J. Yeates
Sherlock and Tolo create CRISPR agreement
Sherlock Biosciences gains exclusive rights to Tolo Biotech’s Cas12 technology
Articles
| 2 min read
by
Mel J. Yeates
Confirmed: COVID-19 has outsized impact on Black and Hispanic populations
Black and Hispanic populations’ heightened risk of exposure and transmission is primary factor of impact
News
| 2 min read
by
Mel J. Yeates
Onto the Fast Track for MarzAA
Catalyst Biosciences gains FDA Fast Track designation for subcutaneous MarzAA for the treatment of Hemophilia
News
| 4 min read
by
Mel J. Yeates
Defeating Venezuelan equine virus with a decoy
A decoy molecule could help to contain outbreaks of Venezuelan equine encephalitis infection
Articles
| 3 min read
by
Mel J. Yeates
Finding new drugs with fungi
NIH grant will help researchers learn ways to counter drug resistance via gene editing
Articles
| 3 min read
by
Mel J. Yeates
Developing a cell therapy control switch
Nutrient-based safety switches can be applied to CAR-T, stem cell and TCR therapies
Articles
| 3 min read
by
Mel J. Yeates
Building a database around RNA and proteins
eCLIP technology helps uncover how RNA binding proteins regulate gene expression
Articles
| 3 min read
by
Mel J. Yeates
BioNTech and Pfizer report BNT162b2 data
BNT162b2 immunization of rhesus macaques results in strong antiviral effects against SARS-CoV-2
Articles
| 3 min read
by
Mel J. Yeates
New means for managing myotonic dystrophy
RNA-targeting gene therapy reverses molecular and functional features of DM1 in mice
Articles
Page 6 of 48 - 574 Total Items
2
3
4
5
6
7
8
9
10
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
Subscribe
Sponsored
A new era of therapeutic antibodies
Explore the scientific advances driving more specific, potent, and adaptable antibody-based therapies.
Ebooks
Rapid sterility testing for advanced therapy manufacturing
Explore how digital PCR is reshaping sterility testing to support faster, more reliable release of advanced therapy medicinal products.
Articles
Milestone: The parallel evolution of organoids and high-content imaging
Explore how breakthroughs in fast confocal imaging and 3D cell culture converged to transform the study of complex human biology
in vitro.
Milestones
Latest Issue
Volume 21 • Issue 4 • December 2025
December 2025
December 2025 Issue
Explore this issue